SS
LTRN icon

SBI Securities’s Lantern Pharma LTRN Stock Holding History

SBI Securities’s Portfolio LTRN Stock Details LTRN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$9K Buy
2,159
+15
+0.7% +$44 ﹤0.01% 1890
2026
Q1 		$2.94K Buy
2,144
+1
+0% +$3 ﹤0.01% 2273
2025
Q4 		$6.49K Hold
2,143
– – ﹤0.01% 1912
2025
Q3 		$9.32K Sell
2,143
-11
-0.5% -$46 ﹤0.01% 1802
2025
Q2 		$6.81K Buy
2,154
+10
+0.5% +$34 ﹤0.01% 1856
2025
Q1 		$7.59K Buy
2,144
+36
+2% +$149 ﹤0.01% 1716
2024
Q4 		$6.72K Buy
+2,108
New +$7.22K ﹤0.01% 1805

Other funds holding LTRN

WIM
Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return
DC
Davenport & Co Richmond, Virginia $20.4B AUM 18.11% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $12.8B AUM 26.53% 1-Year Est. Return
EF
Entrust Financial Wayne, Pennsylvania $154M AUM
PWA
Physician Wealth Advisors Midvale, Utah $837M AUM 26% 1-Year Est. Return
KFI
Key Financial Inc West Chester, Pennsylvania $611M AUM 21.11% 1-Year Est. Return

SBI Securities's LTRN Position: Q2 2026 in Review

SBI Securities increased its Lantern Pharma (LTRN) stake by 0.7% in Q2 2026, buying an estimated $44 and bringing the position to 2,159 shares worth $9K. The position accounts for ﹤0.01% of the portfolio, ranked #1890.

SBI Securities first reported a position in LTRN in Q4 2024 and has held it in 7 quarters since. The position peaked at $9.32K in Q3 2025. 8 funds tracked by Wall St. Rank hold LTRN as of Q2 2026.

  • SBI Securities held 2,159 shares of Lantern Pharma worth $9K as of Q2 2026.
  • SBI Securities bought 15 Lantern Pharma shares in Q2 2026, an estimated $44.
  • Lantern Pharma made up ﹤0.01% of SBI Securities's portfolio in Q2 2026, its #1890 holding.
  • SBI Securities first reported a position in Lantern Pharma in Q4 2024 and has held it in 7 quarters since.
  • SBI Securities's Lantern Pharma position peaked at $9.32K in Q3 2025.
  • 8 funds tracked by Wall St. Rank held Lantern Pharma as of Q2 2026.

Based on SBI Securities's 13F filing for Q2 2026, filed 23 Jul 2026.